DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17

Clinical trials for DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17 explained in plain language.

Never miss a new study

Get alerted when new DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17 trials appear

Sign up with your email to follow new studies for DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Could a simple zinc pill help control a rare brain disorder?

Disease control Completed

This small pilot study tested whether taking a daily zinc supplement for six months is safe and practical for people with GNAO1 disorders, a rare genetic condition that causes movement problems, seizures, and developmental delays. Researchers enrolled 13 participants, aged 6 mont…

Matched conditions: DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17

Phase: PHASE2 • Sponsor: Children's University Hospital Cologne, Germany • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17

Get alerted when new DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17 trials appear

Could a simple zinc pill help control a rare brain disorder?